Build vs. buy in healthcare software comes down to one question: does this system touch your core clinical differentiator, or is it commodity infrastructure? Buy the commodity pieces. Build only the parts that make your product genuinely different. Most teams get this backwards, and it costs them months.
In my decade working with healthcare teams, I've watched the same mistake play out dozens of times. A team buys a rigid platform for something that needed custom logic, or builds a custom system for something a vendor already solved. Both paths waste budget. This guide walks through when each choice actually makes sense, backed by real failure data, not guesswork.
What Does Build vs. Buy in Healthcare Software Actually Mean?
Build vs. buy in healthcare software is the decision between developing a custom application in-house (or with a partner) versus licensing an existing platform. It matters more in healthcare than in most industries because compliance requirements, clinical workflows, and EHR interoperability rarely fit a generic off-the-shelf product cleanly.
A third option sits between the two: hybrid, or composable, where you license a core platform and build a differentiation layer on top. Most real healthcare software decisions end up here, not at either extreme. The mistake isn't picking build or buy. It's picking one without checking whether hybrid fits better.
Why Do Healthcare Software Projects Fail So Often?
Healthcare software projects fail at a strikingly high rate because vendor promises rarely match clinical reality, and workflows get bolted on instead of designed in from day one. According to Artezio's analysis of 247 hospital software implementations, 73 percent of hospital software projects end in complete or partial failure. Only 12 percent count as a full success.
Failure rates vary sharply by project type, and that variance is exactly what a build vs. buy decision should account for:
Project type | Failure rate |
EHR migration (vendor switch) | 87% |
EHR implementation (new system) | 81% |
Clinical decision support | 77% |
Patient portal or engagement tool | 68% |
Telehealth platform | 64% |
Custom integration platform | 43% |
Notice that custom integration platforms, the most "build-heavy" category here, actually fail less often than full EHR replacements. That's a useful signal: narrow, purpose-built systems tend to outperform sprawling, one-size-fits-all replacements, in either direction.
When Should You Buy Healthcare Software Instead of Building It?
Buy healthcare software when the problem is a solved commodity, not a competitive differentiator. Core infrastructure, standardized communication tools, established EHR integrations, and back-office operations almost always fall into this category, since dozens of vendors have already solved them well.
A few concrete signals that buying is the right call:
The workflow is common across most healthcare organizations, not unique to yours
A HIPAA-compliant vendor already exists with a track record in your specific niche
Speed to market matters more than deep customization right now
Your team lacks in-house capacity to maintain custom code for years
According to Arkenea's 2026 healthcare software cost guide, HIPAA compliance alone adds 15 to 25 percent to any healthcare project's cost, whether you build or buy. Buying a platform that already has this baked in often beats paying that premium twice.
When Does It Make Sense to Build Healthcare Software From Scratch?
Building from scratch makes sense when the software is your core differentiator, meaning your competitive advantage depends on logic or workflows no vendor offers. Proprietary clinical algorithms, highly specific provider workflows, and deep patient engagement models usually belong in this bucket.
There's a real financial case for this path too. Companies with proprietary technology see roughly twice the revenue growth of peers relying on off-the-shelf tools, according to Deloitte research cited by Neontri. If the system you're evaluating is the thing customers actually pay you for, building it yourself protects that advantage instead of handing it to a vendor's roadmap.
The catch is capacity. Our digital engineering team tells clients the same thing before any custom build starts: budget for multi-year maintenance, not just the initial launch. A custom EHR or clinical platform typically costs $100,000 to $500,000 or more to build, and ongoing maintenance runs another 15 to 25 percent of that every year.
What Is the Hybrid Trap in Healthcare Software Customization?
The hybrid trap is what happens when you customize a purchased platform past the point where buying still made sense. Once customization crosses roughly 20 percent of the platform's core functionality, you're often paying more than a custom build would have cost. You also end up with a system that's harder to maintain than either pure option.
This trap catches healthcare teams constantly, because clinical workflows resist generic software by nature. A vendor's patient intake flow almost works for your specialty clinic, so you customize it. Then you customize the next piece, and the next. Eighteen months later, you're maintaining a fragile, over-modified platform that costs more than the custom build you avoided, and upgrades from the vendor keep breaking your changes.
Build vs. Buy vs. Hybrid: Comparing Costs and Timelines
Here's how the three paths compare once you account for realistic healthcare compliance overhead, not just sticker price.
Approach | Upfront cost | Timeline | Best for |
Buy | $10K to $80K/year licensing | 4 to 12 weeks | Commodity workflows, fast launch |
Hybrid | $50K to $200K + license fees | 3 to 6 months | Mostly standard workflows, one key differentiator |
Build | $100K to $500K+ | 6 to 18 months | Core clinical IP, long-term differentiation |
These numbers assume a mid-sized healthcare software project. Enterprise hospital systems or highly regulated medical device software can run well past the top of these ranges, especially once FDA SaMD classification enters the picture.
How Do You Calculate the Real Total Cost of Ownership?
Calculating true total cost of ownership means adding five years of maintenance, compliance updates, and integration work to the sticker price, not just comparing initial quotes. Hidden costs are where most build vs. buy decisions actually go wrong.
Start with the license or build cost. This is the number most teams stop at, and it's the least useful one on its own.
Add annual maintenance. Budget 15 to 25 percent of the initial cost every year, whether you built or bought.
Add integration costs per system. EHR integrations alone can run $15,000 to $80,000 depending on depth, according to Taction Software's 2026 healthcare cost guide.
Add compliance and audit overhead. HIPAA, and FDA requirements if applicable, don't disappear after launch. They recur every year.
Add the hidden vendor markup. SaaS licensing costs can run 150 to 200 percent above the sticker price over five years, according to Gartner research cited by Neontri, once seat growth and add-on modules are counted.
Run these five steps side by side for build, buy, and hybrid before you sign anything. The cheapest option in year one is rarely the cheapest option in year five.
What Questions Should You Ask Before Committing to Build or Buy?
Before committing to either path, ask whether the system is a commodity or a core differentiator, since that single question resolves most build vs. buy debates in healthcare software. The rest of the questions below sharpen that first answer.
Does a HIPAA-compliant, healthcare-specific vendor already solve this problem well?
Will you need more than 20 percent customization to fit your actual workflow?
Is this system the reason customers choose you over a competitor?
Can your team realistically maintain custom code for the next five years?
Have you modeled the five-year total cost of ownership, not just the launch budget?
Does the timeline pressure favor buying now and building differentiation later?
Standish Group research shows more than 35 percent of large enterprise custom software initiatives get abandoned before completion. Only 29 percent are delivered successfully, according to findings cited by Neontri. Answering these questions honestly before you start is what separates the successful 29 percent from the rest.
How Noseberry Approaches Build vs. Buy Decisions for Healthcare Clients
At Noseberry, we don't pitch build or buy by default. We map the client's actual differentiator first, then recommend whichever path protects it without overspending. That's the whole job, honestly, and it's why most of our healthcare engagements start with a scoping conversation before a single line of code.
When a client's core value is a proprietary clinical workflow, Noseberry builds it. We usually start narrow, with our AI consultancy team scoping the minimum viable version before scaling up. When the need is standardized infrastructure, Noseberry often recommends buying and spending the saved budget on the one workflow that actually differentiates the client. Our data engineering team handles the integration work either way, since that's usually where healthcare projects break down regardless of the build or buy call.
Our AI product assurance team also runs a compliance and workflow-fit review before any recommendation ships. The 73 percent hospital software failure rate above is largely preventable with better upfront diagnosis. You can see examples of this approach across our case studies page.
Conclusion
Build vs. buy in healthcare software isn't a coin flip, and it isn't a permanent allegiance to one approach either. The right call depends entirely on whether the system in question is your competitive differentiator or a solved commodity problem. Most real decisions land in a hybrid middle, not a pure extreme.
Here's the single number worth remembering from everything above. Healthcare software projects fail 73 percent of the time, mostly because teams skip the diagnostic step and jump straight to a build or buy decision. Run the five-year total cost of ownership math. Check the 20 percent customization threshold. Ask whether the system is truly your differentiator before you commit a budget to either path.
If you're weighing a build vs. buy decision right now, don't guess at which bucket your project falls into. Our team at Noseberry can walk through your specific workflow and compliance requirements before you commit to either path. Get in touch and we'll help you scope it honestly, even if that means recommending you buy instead of hiring us to build.
